Connor Clark & Lunn Investment Management Ltd. Increases Stake in ICU Medical, Incorporated (ICUI)

Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 693.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,350 shares of the medical instruments supplier’s stock after acquiring an additional 5,550 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in ICU Medical were worth $1,795,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the stock. BlackRock Inc. lifted its holdings in shares of ICU Medical by 8.3% during the 3rd quarter. BlackRock Inc. now owns 1,431,253 shares of the medical instruments supplier’s stock valued at $404,685,000 after acquiring an additional 109,396 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in shares of ICU Medical by 0.5% during the 3rd quarter. Janus Henderson Group PLC now owns 1,370,845 shares of the medical instruments supplier’s stock valued at $387,606,000 after acquiring an additional 7,475 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of ICU Medical by 15.6% during the 3rd quarter. Wells Fargo & Company MN now owns 507,855 shares of the medical instruments supplier’s stock valued at $143,595,000 after acquiring an additional 68,347 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of ICU Medical by 1.1% during the 2nd quarter. Renaissance Technologies LLC now owns 312,500 shares of the medical instruments supplier’s stock valued at $91,766,000 after acquiring an additional 3,400 shares in the last quarter. Finally, OppenheimerFunds Inc. lifted its holdings in shares of ICU Medical by 58.1% during the 2nd quarter. OppenheimerFunds Inc. now owns 225,807 shares of the medical instruments supplier’s stock valued at $66,308,000 after acquiring an additional 82,976 shares in the last quarter. Institutional investors and hedge funds own 75.97% of the company’s stock.

In other ICU Medical news, Director Pfizer Inc sold 2,500,000 shares of the business’s stock in a transaction on Thursday, November 15th. The shares were sold at an average price of $209.25, for a total value of $523,125,000.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 12.50% of the company’s stock.

Shares of ICUI stock opened at $238.25 on Friday. ICU Medical, Incorporated has a 12 month low of $205.55 and a 12 month high of $321.70. The firm has a market capitalization of $4.89 billion, a price-to-earnings ratio of 43.16 and a beta of 0.62.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.51 by $0.34. ICU Medical had a net margin of 6.00% and a return on equity of 15.20%. The firm had revenue of $327.20 million for the quarter, compared to analyst estimates of $334.97 million. During the same quarter in the previous year, the business posted $1.12 EPS. The firm’s revenue was down 4.7% compared to the same quarter last year. Equities analysts expect that ICU Medical, Incorporated will post 7.76 earnings per share for the current fiscal year.

ICUI has been the topic of several recent research reports. TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th. ValuEngine upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, September 28th. Finally, Zacks Investment Research lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Saturday, November 10th.

WARNING: This piece was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/12/07/connor-clark-lunn-investment-management-ltd-increases-stake-in-icu-medical-incorporated-icui.html.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

See Also: Do You Need a Fiduciary?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply